Home » About Us » Our Team » Constantine G. Lyketsos, M.D., M.H.S.

Constantine G. Lyketsos, M.D., M.H.S.

ADRC Associate Director
Clinical Core Leader
E-mail: [email protected]

Dr. Lyketsos is the Elizabeth Plank Althouse Professor for Alzheimer’s Research. He is the Chair of Psychiatry at the Johns Hopkins Bayview Medical Center.

Dr. Lyketsos’ research interests include the epidemiology and treatment of neuropsychiatric disorders in dementia, and the etiology and effect of neuropsychiatric symptoms occurring across the spectrum of Alzheimer’s disease and related dementias.


  • O’Bryant S, Zhang F, Johnson L, Hall J, Petersen M, Oh E, Lyketsos C, Rissman R.  Precision medicine for preventing Alzheimer’s Disease: Analysis of the ADAPT Study. J Alzheimers Dis, 2023; 95: 1609-1622.
  • Lyketsos CG, Roberts S, Swift E, Quina A, Moon G, Kremer J, Tariot P, Fillit H, Bovenkamp P, Zandi P, Haaga J. Standardizing electronic health record data on AD/ADRD to accelerate health equity in prevention, detection and treatment. J Preven Alzheimers Dis, 2022; 9: 556-560.
  • Ismail Z, Aquiera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer C, Gauthier S, Geda Y, Hermann N, Kanji J, Lanctot K, Miller D, Mortby M, Onyike C, Rosenberg P, Smith E, Smith G, Sultzer D, Lyketsos C. The Mild Behavioral Impairment Checklist (MBI-C): A rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimers Dis 2017; 56: 929-938.
  • Schneider L, Frangakis C, Drye L, Devanand D, Marano C, Mintzer M, Mulsant B, Munro C, Newall J, Pawluczyk S, Pelton G, Pollock B, Porsteinsson A, Rabins P, Rein L, Rosenberg P, Shade D, Weinstraub D, Yesavage J, Lyketsos C. Heterogeneity of treatment response to citalopram for patients with Alzheimer’s disease with aggression or agitation: The CitAD Randomized Clinical Trial. Am J Psychiatry, 2016; 173: 465-472.


Primary Appointment in Psychiatry & Behavioral Sciences